The devastating effects of stroke can be irreversible, leading to loss of neurons and even death. However, researchers have made a groundbreaking discovery that may change this grim reality. A team led by Osaka Metropolitan University Associate Professor Hidemitsu Nakajima has developed a revolutionary drug called GAI-17, which inhibits the protein GAPDH involved in cell death.

GAPDH, or glyceraldehyde-3-phosphate dehydrogenase, is a multifunctional protein linked to various debilitating brain and nervous system diseases. The team’s innovative approach was to create an inhibitor that targets this protein, preventing its toxic effects on neurons. When administered to model mice with acute strokes, GAI-17 showed astonishing results: significantly reduced brain cell death and paralysis compared to untreated animals.

The significance of GAI-17 extends far beyond stroke treatment. Experiments revealed no adverse effects on the heart or cerebrovascular system, making it a promising candidate for addressing other intractable neurological diseases, including Alzheimer’s disease. Moreover, the drug demonstrated remarkable efficacy even when administered six hours after a stroke – a critical window that could revolutionize stroke care.

“We believe our GAPDH aggregation inhibitor has the potential to be a single treatment for many debilitating neurological conditions,” Professor Nakajima expressed. “We will continue to explore its effectiveness in various disease models and strive towards creating a healthier, longer-lived society.”

The article highlights a disturbing trend in the United States – cancer deaths linked to obesity have tripled over the past two decades. A study presented at the Endocrine Society’s annual meeting in San Francisco examined more than 33,000 deaths from obesity-associated cancers and revealed sharp increases in cancer deaths, particularly among women, older adults, Native Americans, and Black Americans.

“Obesity is a significant risk factor for multiple cancers, contributing to significant mortality,” said lead researcher Faizan Ahmed. “This research underscores the need for targeted public health strategies such as early screening and improved access to care, especially in high-risk rural and underserved areas.”

The study used mortality data from the Centers for Disease Control and Prevention (CDC) to analyze U.S. deaths from obesity-associated cancers between 1999 and 2020. The results showed age-adjusted mortality rates increased from 3.73 to 13.52 per million over two decades, with steep increases among certain groups.

Obesity is a complex disease resulting from multiple genetic, physiological, hormonal, environmental, and developmental factors. It raises the risk of developing serious chronic conditions such as high blood pressure, high cholesterol, prediabetes, type 2 diabetes, heart disease, and chronic and end-stage kidney disease.

In addition to certain types of cancer, obesity is associated with a higher risk of developing 13 types of cancer, according to the CDC. These cancers make up 40% of all cancers diagnosed in the United States each year.

The regions with the highest rates of obesity-related cancer deaths were identified as follows:

* The Midwest had the highest rate.
* Vermont, Minnesota, and Oklahoma had the highest state-level rates.
* Utah, Alabama, and Virginia had the lowest state-level rates.

This research emphasizes the need for targeted public health strategies to combat the growing epidemic of obesity-related cancer deaths. Early screening and improved access to care are crucial in reducing mortality rates among high-risk groups.

“Deadly Disguise: How Candy-Like Nicotine Pouches Led to a 763% Spike in Child Poisonings”

A new study has revealed that ingestions of nicotine pouches by young children have surged in recent years. Researchers at the Center for Injury Research and Policy of the Abigail Wexner Research Institute at Nationwide Children’s Hospital and the Central Ohio Poison Center analyzed calls to U.S. poison centers and found a staggering 763% increase in the rate of reported nicotine pouch ingestions among children younger than 6 years old from 2020 to 2023.

Nicotine pouches, which contain nicotine powder and are placed in the mouth, were not tracked in national poison center data until 2020. However, between 2020 and 2023 (the most recent year of data from the study), the rate of unintentional ingestion of nicotine pouches by young children increased at a fast rate – even as ingestion rates for other formulations of nicotine declined.

“The rapid increase in the number and comparative severity of nicotine pouch ingestions is a reminder of the public health challenges of the changing nicotine product market,” said Hannah Hays, MD, co-author of the study and medical director of the Central Ohio Poison Center. “This is why we need to continue ongoing surveillance and increase our efforts to prevent nicotine ingestions among young children.”

The study, published in Pediatrics, also investigated other nicotine products and formulations. Researchers examined nearly 135,000 cases of nicotine ingestions among children younger than 6 years old that were reported to U.S. poison centers from 2010 through 2023. Most ingestions occurred at home and involved children under the age of 2 years.

While most exposures resulted in minor or no effects, there were 39 cases with major medical outcomes and two deaths. The overall rate of all nicotine ingestions increased 59% from 2010-2015 before decreasing 34% from 2015-2023. This rate was primarily driven by the ingestion rate for liquid nicotine and nicotine solid formulations such as tablets, capsules, and caplets.

The study’s findings have significant implications for public health policy and prevention strategies. “Many nicotine products are flavored and sold in colorful packaging that may be attractive to a young child,” said Gary Smith, MD, DrPH, senior author of the study and director of the Center for Injury Research and Policy at Nationwide Children’s. “Banning flavors in all nicotine products helps reduce unintentional ingestions by young children as well as discourage use among teens.”

Researchers also shared a few safety tips for parents and caregivers of young children. The safest choice is to keep all nicotine products out of the home. If you choose to have them in your home, you can lower the risk by following these steps:

* Store nicotine products safely and securely.
* Keep an eye on your child at all times when they are in the same room as nicotine products.
* Be aware of the potential for accidental ingestion and take immediate action if it occurs.

By taking these precautions, parents and caregivers can help prevent nicotine poisonings among young children.